New York City, NY,28 March, 2018/24 Market Reports: Global latest Pharmaceutical and Healthcare disease pipeline guide Atopic Dermatitis Pipeline Review, H1 2018, provides an overview of the Atopic Dermatitis Dermatology pipeline landscape. Atopic Dermatitis market report offers in-depth insights, revenue details, and other vital information regarding the global Atopic Dermatitis market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025.
Atopic dermatitis is an itchy inflammation of skin. Signs and symptoms of atopic dermatitis include red to brownishgray colored patches, itching, which may be severe, especially at night, small, raised bumps, which may leak fluid and crust over when scratched, thickened, cracked or scaly skin and raw, sensitive skin from scratching. Risk factors include family history of eczema, allergies, hay fever or asthma and gender.
Report Highlights
Global Markets Directs Pharmaceutical and Healthcare latest pipeline guide Atopic Dermatitis Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Atopic Dermatitis Dermatology, complete with analysis by stage of development, drug target, mechanism of action MoA, route of administration RoA and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Atopic Dermatitis Dermatology pipeline guide also reviews of key players involved in therapeutic development for Atopic Dermatitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 9, 34, 19, 43, 18 and 2 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 1, 2, 3 and 1 molecules, respectively.
Atopic Dermatitis Dermatology pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Atopic Dermatitis Dermatology.
- The pipeline guide reviews pipeline therapeutics for Atopic Dermatitis Dermatology by companies and universities/research institutes based on information derived from company and industryspecific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from preregistration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Atopic Dermatitis Dermatology therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Atopic Dermatitis Dermatology therapeutics based on mechanism of action MoA, drug target, route of administration RoA and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Atopic Dermatitis Dermatology
Get the Complete Report & TOC @ https://www.24marketreports.com/life-sciences/atopic-dermatitispipeline-review-h1-2018-market-77